Skip to main content
Erschienen in: Calcified Tissue International 5/2012

01.05.2012 | Original Research

Two Molecular Weight Species of Thrombospondin-2 Are Present in Bone and Differentially Modulated in Fractured and Nonfractured Tibiae in a Murine Model of Bone Healing

verfasst von: Andrea I. Alford, Anita B. Reddy, Steven A. Goldstein, Prithvi Murthy, Riyad Tayim, Gorav Sharma

Erschienen in: Calcified Tissue International | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

We report two immuoreactive species of thrombospondin-2 (TSP2), sized approximately 200 and 125 kDa, in the long bones of growing, but not skeletally mature, mice. In vitro osteoblasts secrete a 200-kDa species into the culture medium as early as day 3, and it appears in the cell-matrix layer by day 7. A 125-kDa species appears in the cell-matrix layer in parallel with mineralization; it is not detected in cell-conditioned medium. Unilateral tibial fracture induced a time-dependent upregulation of the 200-kDa species at the site of trauma. By contrast, relative levels of the 125-kDa species at the fracture site were lower than in bones from naive control animals. In the contralateral untouched control tibia, the 200-kDa species was rapidly and substantially reduced compared to bone harvested from naive control mice. Levels of the 125-kDa species in the untouched tibia declined gradually with time postfracture. TSP2 gene expression in uninjured control bone decreased modestly by 21 days postfracture. On the day of fracture, the osteoblast differentiation potential of MSCs harvested from uninjured bones decreased compared to those harvested from naive control animals. The presence of two isoforms suggests that TSP2 may undergo posttranscriptional or posttranslational processing in skeletal tissue. Our data also suggest that, in the context of trauma, the two TSP2 isforms are differentially modulated at injured and noninjured skeletal sites in an animal undergoing fracture healing.
Literatur
1.
Zurück zum Zitat Bornstein P, Sage E (2002) Matricellular proteins: extracellular modulators of cell function. Curr Opin Cell Biol 14:608–616PubMedCrossRef Bornstein P, Sage E (2002) Matricellular proteins: extracellular modulators of cell function. Curr Opin Cell Biol 14:608–616PubMedCrossRef
2.
Zurück zum Zitat Bornstein P, Armstrong LC, Hankenson KD, Kyriakides TR, Yang Z (2000) Thrombospondin 2, a matricellular protein with diverse functions. Matrix Biol 19:557–568PubMedCrossRef Bornstein P, Armstrong LC, Hankenson KD, Kyriakides TR, Yang Z (2000) Thrombospondin 2, a matricellular protein with diverse functions. Matrix Biol 19:557–568PubMedCrossRef
3.
Zurück zum Zitat Hankenson KD, Bain SD, Kyriakides TR, Smith EA, Goldstein SA, Bornstein P (2000) Increased marrow-derived osteoprogenitor cells and endosteal bone formation in mice lacking thrombospondin 2. J Bone Miner Res 15:851–862PubMedCrossRef Hankenson KD, Bain SD, Kyriakides TR, Smith EA, Goldstein SA, Bornstein P (2000) Increased marrow-derived osteoprogenitor cells and endosteal bone formation in mice lacking thrombospondin 2. J Bone Miner Res 15:851–862PubMedCrossRef
4.
Zurück zum Zitat Hankenson KD, Bornstein P (2002) The secreted protein thrombospondin 2 is an autocrine inhibitor of marrow stromal cell proliferation. J Bone Miner Res 17:415–425PubMedCrossRef Hankenson KD, Bornstein P (2002) The secreted protein thrombospondin 2 is an autocrine inhibitor of marrow stromal cell proliferation. J Bone Miner Res 17:415–425PubMedCrossRef
5.
Zurück zum Zitat Alford AI, Terkhorn SP, Reddy AB, Hankenson KD (2010) Thrombospondin-2 regulates matrix mineralization in MC3T3-E1 pre-osteoblasts. Bone 46:464–471PubMedCrossRef Alford AI, Terkhorn SP, Reddy AB, Hankenson KD (2010) Thrombospondin-2 regulates matrix mineralization in MC3T3-E1 pre-osteoblasts. Bone 46:464–471PubMedCrossRef
6.
Zurück zum Zitat Shitaye HS, Terkhorn SP, Combs JA, Hankenson KD (2010) Thrombospondin-2 is an endogenous adipocyte inhibitor. Matrix Biol 29:549–556PubMedCrossRef Shitaye HS, Terkhorn SP, Combs JA, Hankenson KD (2010) Thrombospondin-2 is an endogenous adipocyte inhibitor. Matrix Biol 29:549–556PubMedCrossRef
7.
Zurück zum Zitat Taylor DK, Meganck JA, Terkhorn S, Rajani R, Naik A, O’Keefe RJ, Goldstein SA, Hankenson KD (2009) Thrombospondin-2 influences the proportion of cartilage and bone during fracture healing. J Bone Miner Res 24:1043–1054PubMedCrossRef Taylor DK, Meganck JA, Terkhorn S, Rajani R, Naik A, O’Keefe RJ, Goldstein SA, Hankenson KD (2009) Thrombospondin-2 influences the proportion of cartilage and bone during fracture healing. J Bone Miner Res 24:1043–1054PubMedCrossRef
8.
Zurück zum Zitat Volpert OV, Tolsma SS, Pellerin S, Feige JJ, Chen H, Mosher DF, Bouck N (1995) Inhibition of angiogenesis by thrombospondin-2. Biochem Biophys Res Commun 217:326–332PubMedCrossRef Volpert OV, Tolsma SS, Pellerin S, Feige JJ, Chen H, Mosher DF, Bouck N (1995) Inhibition of angiogenesis by thrombospondin-2. Biochem Biophys Res Commun 217:326–332PubMedCrossRef
9.
Zurück zum Zitat Kyriakides TR, Zhu YH, Smith LT, Bain SD, Yang Z, Lin MT, Danielson KG, Iozzo RV, LaMarca M, McKinney CE, Ginns EI, Bornstein P (1998) Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J Cell Biol 140:419–430PubMedCrossRef Kyriakides TR, Zhu YH, Smith LT, Bain SD, Yang Z, Lin MT, Danielson KG, Iozzo RV, LaMarca M, McKinney CE, Ginns EI, Bornstein P (1998) Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J Cell Biol 140:419–430PubMedCrossRef
10.
Zurück zum Zitat Hiltunen A, Vuorio E, Aro HT (1993) A standardized experimental fracture in the mouse tibia. J Orthop Res 11:305–312PubMedCrossRef Hiltunen A, Vuorio E, Aro HT (1993) A standardized experimental fracture in the mouse tibia. J Orthop Res 11:305–312PubMedCrossRef
11.
Zurück zum Zitat Aubin JE (1999) Osteoprogenitor cell frequency in rat bone marrow stromal populations: role for heterotypic cell–cell interactions in osteoblast differentiation. J Cell Biochem 72:396–410PubMedCrossRef Aubin JE (1999) Osteoprogenitor cell frequency in rat bone marrow stromal populations: role for heterotypic cell–cell interactions in osteoblast differentiation. J Cell Biochem 72:396–410PubMedCrossRef
12.
Zurück zum Zitat Carlson CB, Lawler J, Mosher DF (2008) Structures of thrombospondins. Cell Mol Life Sci 65:672–686PubMedCrossRef Carlson CB, Lawler J, Mosher DF (2008) Structures of thrombospondins. Cell Mol Life Sci 65:672–686PubMedCrossRef
13.
Zurück zum Zitat Lee NV, Sato M, Annis DS, Loo JA, Wu L, Mosher DF, Iruela-Arispe ML (2006) ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2. EMBO J 25:5270–5283PubMedCrossRef Lee NV, Sato M, Annis DS, Loo JA, Wu L, Mosher DF, Iruela-Arispe ML (2006) ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2. EMBO J 25:5270–5283PubMedCrossRef
14.
Zurück zum Zitat Lind T, McKie N, Wendel M, Racey SN, Birch MA (2005) The hyalectan degrading ADAMTS-1 enzyme is expressed by osteoblasts and up-regulated at regions of new bone formation. Bone 36:408–417PubMedCrossRef Lind T, McKie N, Wendel M, Racey SN, Birch MA (2005) The hyalectan degrading ADAMTS-1 enzyme is expressed by osteoblasts and up-regulated at regions of new bone formation. Bone 36:408–417PubMedCrossRef
15.
Zurück zum Zitat Rehn AP, Birch MA, Karlstrom E, Wendel M, Lind T (2007) ADAMTS-1 increases the three-dimensional growth of osteoblasts through type I collagen processing. Bone 41:231–238PubMedCrossRef Rehn AP, Birch MA, Karlstrom E, Wendel M, Lind T (2007) ADAMTS-1 increases the three-dimensional growth of osteoblasts through type I collagen processing. Bone 41:231–238PubMedCrossRef
16.
Zurück zum Zitat Manduca P, Castagnino A, Lombardini D, Marchisio S, Soldano S, Ulivi V, Zanotti S, Garbi C, Ferrari N, Palmieri D (2009) Role of MT1-MMP in the osteogenic differentiation. Bone 44:251–265PubMedCrossRef Manduca P, Castagnino A, Lombardini D, Marchisio S, Soldano S, Ulivi V, Zanotti S, Garbi C, Ferrari N, Palmieri D (2009) Role of MT1-MMP in the osteogenic differentiation. Bone 44:251–265PubMedCrossRef
17.
Zurück zum Zitat Geoffroy V, Marty-Morieux C, Le Goupil N, Clement-Lacroix P, Terraz C, Frain M, Roux S, Rossert J, de Vernejoul MC (2004) In vivo inhibition of osteoblastic metalloproteinases leads to increased trabecular bone mass. J Bone Miner Res 19:811–822PubMedCrossRef Geoffroy V, Marty-Morieux C, Le Goupil N, Clement-Lacroix P, Terraz C, Frain M, Roux S, Rossert J, de Vernejoul MC (2004) In vivo inhibition of osteoblastic metalloproteinases leads to increased trabecular bone mass. J Bone Miner Res 19:811–822PubMedCrossRef
18.
Zurück zum Zitat Kyriakides TR, Zhu YH, Yang Z, Bornstein P (1998) The distribution of the matricellular protein thrombospondin 2 in tissues of embryonic and adult mice. J Histochem Cytochem 46:1007–1015PubMedCrossRef Kyriakides TR, Zhu YH, Yang Z, Bornstein P (1998) The distribution of the matricellular protein thrombospondin 2 in tissues of embryonic and adult mice. J Histochem Cytochem 46:1007–1015PubMedCrossRef
19.
Zurück zum Zitat Bab IA, Einhorn TA (1994) Polypeptide factors regulating osteogenesis and bone marrow repair. J Cell Biochem 55:358–365PubMedCrossRef Bab IA, Einhorn TA (1994) Polypeptide factors regulating osteogenesis and bone marrow repair. J Cell Biochem 55:358–365PubMedCrossRef
20.
Zurück zum Zitat Bab I, Gazit D, Chorev M, Muhlrad A, Shteyer A, Greenberg Z, Namdar M, Kahn A (1992) Histone H4-related osteogenic growth peptide (OGP): a novel circulating stimulator of osteoblastic activity. EMBO J 11:1867–1873PubMed Bab I, Gazit D, Chorev M, Muhlrad A, Shteyer A, Greenberg Z, Namdar M, Kahn A (1992) Histone H4-related osteogenic growth peptide (OGP): a novel circulating stimulator of osteoblastic activity. EMBO J 11:1867–1873PubMed
21.
Zurück zum Zitat Brager MA, Patterson MJ, Connolly JF, Nevo Z (2000) Osteogenic growth peptide normally stimulated by blood loss and marrow ablation has local and systemic effects on fracture healing in rats. J Orthop Res 18:133–139PubMedCrossRef Brager MA, Patterson MJ, Connolly JF, Nevo Z (2000) Osteogenic growth peptide normally stimulated by blood loss and marrow ablation has local and systemic effects on fracture healing in rats. J Orthop Res 18:133–139PubMedCrossRef
22.
Zurück zum Zitat Amsel S, Maniatis A, Tavassoli M, Crosby WH (1969) The significance of intramedullary cancellous bone formation in the repair of bone marrow tissue. Anat Rec 164:101–111PubMedCrossRef Amsel S, Maniatis A, Tavassoli M, Crosby WH (1969) The significance of intramedullary cancellous bone formation in the repair of bone marrow tissue. Anat Rec 164:101–111PubMedCrossRef
23.
Zurück zum Zitat Gazit D, Karmish M, Holzman L, Bab I (1990) Regenerating marrow induces systemic increase in osteo- and chondrogenesis. Endocrinology 126:2607–2613PubMedCrossRef Gazit D, Karmish M, Holzman L, Bab I (1990) Regenerating marrow induces systemic increase in osteo- and chondrogenesis. Endocrinology 126:2607–2613PubMedCrossRef
24.
Zurück zum Zitat Bab I, Gazit D, Massarawa A, Sela J (1985) Removal of tibial marrow induces increased formation of bone and cartilage in rat mandibular condyle. Calcif Tissue Int 37:551–555PubMedCrossRef Bab I, Gazit D, Massarawa A, Sela J (1985) Removal of tibial marrow induces increased formation of bone and cartilage in rat mandibular condyle. Calcif Tissue Int 37:551–555PubMedCrossRef
25.
Zurück zum Zitat Pignolo RJ, Kassem M (2011) Circulating osteogenic cells: implications for injury, repair, and regeneration. J Bone Miner Res 26:1685–1693PubMedCrossRef Pignolo RJ, Kassem M (2011) Circulating osteogenic cells: implications for injury, repair, and regeneration. J Bone Miner Res 26:1685–1693PubMedCrossRef
26.
Zurück zum Zitat Kumagai K, Vasanji A, Drazba JA, Butler RS, Muschler GF (2008) Circulating cells with osteogenic potential are physiologically mobilized into the fracture healing site in the parabiotic mice model. J Orthop Res 26:165–175PubMedCrossRef Kumagai K, Vasanji A, Drazba JA, Butler RS, Muschler GF (2008) Circulating cells with osteogenic potential are physiologically mobilized into the fracture healing site in the parabiotic mice model. J Orthop Res 26:165–175PubMedCrossRef
27.
Zurück zum Zitat Boban I, Barisic-Dujmovic T, Clark SH (2010) Parabiosis model does not show presence of circulating osteoprogenitor cells. Genesis 48:171–182PubMed Boban I, Barisic-Dujmovic T, Clark SH (2010) Parabiosis model does not show presence of circulating osteoprogenitor cells. Genesis 48:171–182PubMed
Metadaten
Titel
Two Molecular Weight Species of Thrombospondin-2 Are Present in Bone and Differentially Modulated in Fractured and Nonfractured Tibiae in a Murine Model of Bone Healing
verfasst von
Andrea I. Alford
Anita B. Reddy
Steven A. Goldstein
Prithvi Murthy
Riyad Tayim
Gorav Sharma
Publikationsdatum
01.05.2012
Verlag
Springer-Verlag
Erschienen in
Calcified Tissue International / Ausgabe 5/2012
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-012-9580-y

Weitere Artikel der Ausgabe 5/2012

Calcified Tissue International 5/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.